Samtidig brug af indinavir og nukleosidanaloger (over for hvilke patienten er naiv) kan mindske risikoen for udvikling af resistens over for både indinavir og nukleosidanaloger.
The concomitant use of indinavir with nucleoside analogues (to which the patient is naive) may lessen the risk of the development of resistance to both indinavir and the nucleoside analogues.